FDA initiative to reduce unnecessary radiation exposure

Article

The US FDA unveiled an initiative to reduce unnecessary radiation exposure from 3 types of medical imaging procedures that are the greatest contributors to total radiation exposure within the United States.

The US FDA unveiled an initiative to reduce unnecessary radiation exposure from 3 types of medical imaging procedures that are the greatest contributors to total radiation exposure within the United States: computed tomography (CT), nuclear medicine studies, and fluoroscopy.

The FDA initiative has 3 goals: to promote the safe use of medical imaging devices; to support informed clinical decision-making; and to increase patients' awareness of their exposure. The agency expects to issue target requirements for manufacturers of CT and fluoroscopic devices to incorporate safeguards into the design of their machines, to develop safer technologies, and to provide appropriate training to support safe use. Some examples might be requiring that devices display, record, and report equipment settings and radiation dose or an alert when the dose exceeds a diagnostic reference level.

In addition, FDA and CMS are collaborating to incorporate key quality assurance practices into mandatory accreditation. The FDA also recommends that healthcare professional organizations continue to develop diagnostic radiation reference levels for medical imaging procedures and to increase efforts to develop national registries for radiation doses.

FDA unveils initiative to reduce unnecessary radiation exposure from medical imaging [press release]. February 9, 2010. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm200085.htm. Accessed March 11, 2010.

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit: uvahealth.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.